Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...

UnitedHealth extends gains while Dayforce soars following a report that says it could be bought by private-equity firm Thoma ...

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

It has been a rough year for healthcare stocks on the S&P 500, but Warren Buffett’s move into UnitedHealth Group Inc. could ...

UnitedHealth Group Incorporated (NYSE:UNH)’s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided ...

A new report shows how much prices for the same medical service can vary at different hospitals and surgery centers.

If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world, and his annual ...